Buspirone Hydrochloride Tablet
Product Images NDC 51655-511

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 51655-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 511 52)

This is a description of BusPIRone Hydrochloride Tablets USP with NDC number 51655-511-52. The package contains 30 tablets of 7.5mg each and should be stored at 25°C (77°F) with excursions permitted to 15°-30°C (56°-86°F). The dosage instructions are listed in the package insert and the medication should be kept out of reach of children. This medication was repackaged by Northwind Pharmaceuticals from the original packaging labeled with NDC number 16729-201-01. The Lot number and expiration date are both 0000000000.*

FDA Label Image

Dosage Table (Buspirone Fig 1)

This appears to be a set of instructions for medication dosing. Specifically, it provides guidance on how many tablets of different dosages to take depending on what your doctor has prescribed. It mentions tablet options of 15mg and 30mg and suggests taking one-third or two-thirds of a tablet at specific dosages.*

FDA Label Image

Quadrisect Photo (Buspirone Fig 2)

The text seems to be a list of medication dosages for a certain drug. The drug's name or purpose is not mentioned, and there is not enough context to provide more information other than the available dosages: 5 mg and 30 mg tablets.*

FDA Label Image

Buspirone Structural Formula (Buspirone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.